SCHEMBL25859235

SCHEMBL25859235

C=C1COc2ccccc2C1C(N)(O)C(=O)OCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.38
GAA P10253 3/20 0.37
MGAM O43451 1/20 0.37
AMY1A P0DUB6 1/20 0.37
SI P14410 1/20 0.37
MGAM2 Q2M2H8 1/20 0.37
ALDH1A1 P00352 5/20 0.37
MAPT P10636 4/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
TP53 P04637 1/20 0.37
ALOX15 P16050 1/20 0.37
MAPK1 P28482 1/20 0.37
HSD17B10 Q99714 1/20 0.37
KDM4E B2RXH2 4/20 0.36
HPGD P15428 3/20 0.36
RAB9A P51151 2/20 0.36
NPC1 O15118 1/20 0.36
GLA P06280 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25859233 0.78 POLB (0.35) POLBGAAMGAMAMY1ASI
SCHEMBL25859594 0.78 OPRL1 (0.31) GAAMGAMAMY1ASIMGAM2
SCHEMBL25854609 0.74 GAA (0.41) POLBGAAMGAMAMY1ASI
SCHEMBL25854605 0.72 GAA (0.39) POLBGAAMGAMAMY1ASI
SCHEMBL22877253 0.65 CYP3A4 (0.37) GAAALDH1A1KMT2AMAPK1HSD17B10
SCHEMBL11836856 0.64 CYP1A2 (0.46) POLBGAAMGAMAMY1ASI
SCHEMBL18740900 0.64 POLB (0.46) POLBGAAMGAMAMY1ASI
Urethane SCHEMBL1906316 0.63 ALOX15 (0.48) GAAALDH1A1MAPTSMN1; SMN2MEN1
SCHEMBL8618306 0.63 NR3C1 (0.45) GAAALDH1A1MAPK1HSD17B10KDM4E
SCHEMBL22325514 0.62 TSHR (0.46) POLBGAAMGAMAMY1ASI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227437-A1 IMMUNOMODULATOR HITGEN INC (CN) 2023-07-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227437-A1 IMMUNOMODULATOR IL17A, IL2, IL2RA POLB 3397/4885GAA 2382/4885MGAM 2305/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.